Results 191 to 200 of about 104,289 (264)

Biomarker-directed aptamer panels for diagnosis and differentiation of neuroendocrine tumors. [PDF]

J Neuroendocrinol
Kjær MB, Jørgensen AG, Fjelstrup S, Dupont DM, Bus C, Oversoe SK, Kelsen J, Kjems J, Grønbæk H.   +8 more
europepmc   +1 more source

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

VIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

Long-term survival and molecular heterogeneity of sporadic multifocal non-functional pancreatic neuroendocrine tumors. [PDF]

iScience
Peng Y, Yin L, Lu Z, Guo F, Chen J, Tu M, Gao Y, Gao W, Wei J, Li Q, Jiang K, Wu J.   +11 more
europepmc   +1 more source

Outcomes in Orbit‐Sparing Versus Orbit‐Sacrificing Surgery for Sinonasal Malignancies With Orbital Involvement: A Systematic Review and Meta‐Analysis

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Background Sinonasal malignancies with orbital involvement may be managed with orbit‐sacrificing or orbit‐preserving surgical approaches, with a recent shift towards orbital preservation to reduce postoperative morbidity while maintaining oncological success.
Claire Jing‐Wen Tan, Brian Sheng Yep Yeo, Manish Warrier, Jun He Chan, Lu Hui Png, Shuhui Xu, Kimberley LiQin Kiong, Edward C. Kuan, Tze Choong Charn, Neville Wei Yang Teo   +9 more
wiley   +1 more source

Efficacy of surufatinib in advanced Grade 3 neuroendocrine tumors: a real-world, national, multicenter study. [PDF]

Ther Adv Med Oncol
Wang J, Zhang N, Liang Y, Long J, Chi Y, Zhang S, Bai C, Wang Y, Wu Y, Hu H, Hu W, Huang L, Liu Y, Lv H, Song S, Suo A, Wang X, Zhang L, Zhu L, Chen J, Hao J.   +20 more
europepmc   +1 more source

Neuroendocrine Carcinoma of the Head and Neck: A Two‐Decade Institutional Experience

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objectives Primary neuroendocrine carcinoma (NEC) of the head and neck is rare (< 1% of cases) and aggressive, with poorly defined management strategies. This study evaluated clinical characteristics, treatment patterns, and survival outcomes in a single‐institution cohort, identifying factors associated with improved survival.
Micah K. Harris, Katie M. Carlson, Nathan Lu, Anthony Tang, Matthew E. Spector, Joshua D. Smith, Jessica H. Maxwell, Kevin J. Contrera, Seungwon Kim, Steven B. Chinn, Angela Mazul, Shaum S. Sridharan   +11 more
wiley   +1 more source

Interpretable machine learning prognostication of gastroenteropancreatic neuroendocrine tumors across Chinese and United States cohorts. [PDF]

Front Oncol
Fan Y, Yang Y, Wang K, Zhang T, Dong X, Shi Y, Wang M, Li E, Wu Y.   +8 more
europepmc   +1 more source

Perioperative Outcomes of Patients With Pancreatic Neuroendocrine Neoplasms in the Context of Different Body Composition Phenotypes

World Journal of Surgery, EarlyView.
Pancreatic neuroendocrine neoplasms (pNEN) are rare and heterogeneous tumors with increasing incidence. While surgical resection remains the only curative treatment, perioperative outcomes are influenced by patient‐related risk factors. Recent research highlights body composition (BC) as a prognostic marker in oncological and transplantation surgery ...
Fabiola A. Bechtiger, Mariah Herbrich, Hazem K. A. A. Hassan, Jörg Kaiser, Thomas Hank, Magdalena Lewosinska, Deniz Uluk, Osman Öcal, Nicole D. Hildebrand, Steven WM Olde Damink, Franck Billmann, Zoltan Czigany, Mohammed Al‐Saeedi   +12 more
wiley   +1 more source

Surgery for Gastroenteropancreatic Neuroendocrine Tumors with Synchronous Liver Metastasis. [PDF]

Ann Surg Oncol
Pu T, Luberice K, Ghabra S, Friedman LR, Coleman KN, Larrain CM, Lin Y, Akmal SR, Eade AV, Sarvestani AL, Davis JL, Blakely AM, Del Rivero J, Hernandez JM.   +13 more
europepmc   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel, Aureliane Pierret, Edouard G. Mills, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source